Navigation Links
Westaim commences mailing of management information circular and announces new director
Date:3/1/2010

/NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES AND DOES NOT CONSTITUTE AN OFFER OF THE SECURITIES DESCRIBED HEREIN./

TORONTO, March 1 /PRNewswire-FirstCall/ - The Westaim Corporation (Westaim or the Company) (TSX: "WED") announces that it has distributed proxy materials to its transfer agent and intermediaries for mailing to registered and beneficial shareholders in connection with a special meeting of shareholders to be held on March 25, 2010 for the purpose of approving the issuance of up to 550 million common shares of the Corporation issuable upon the conversion of (i) 254 million class A subscription receipts and (ii) 296 million class B subscription receipts (together the Subscription Receipts). The proxy materials consist of a form of proxy and a management information circular dated as of February 26, 2010 (the Circular). The Circular contains details of, among other things, the sale of the Subscription Receipts undertaken by Westaim in order to finance the purchase price in respect of its previously announced acquisition (the Acquisition) of JEVCO Insurance Company (JEVCO), the terms of the Acquisition, the business of JEVCO and certain historical and pro forma financial information relating to JEVCO and Westaim. The form of proxy and Circular (including certain financial information and related MD&A relating to JEVCO) will be available on SEDAR (www.sedar.com) and the Corporation's web page (www.westaim.com).

Westaim also announces the appointment of Mr. Brian Gibson as a director of the Corporation. Mr. Gibson is Senior Vice President, Public Equities of the Alberta Investment Management Corporation (AIMCo). AIMCo is an Alberta crown corporation which is responsible for managing and investing funds on behalf of certain Alberta public sector pension plans, endowments and government funds. It is expected that AIMCo will identify a second nominee prior to or shortly after the completion of the Acquisition.

"We welcome Brian to the Westaim Board and look forward to working with him to complete the Acquisition and integration of JEVCO's business," said Cameron MacDonald, Westaim's President and Chief Executive Officer. "AIMCo has been instrumental in enabling Westaim to pursue the Acquisition and we expect the knowledge and experience of Mr. Gibson to be an important asset for Westaim's Board going forward."

About Westaim

Westaim invests, directly and indirectly, through acquisitions, joint ventures and other arrangements, with the objective of providing its shareholders with capital appreciation and real wealth preservation. Westaim's common shares are listed on The Toronto Stock Exchange under the trading symbol WED.

Certain portions of this press release as well as other public statements by Westaim, contain forward-looking statements. Such forward-looking statements include but are not limited to statements concerning the transactions described herein; investment strategies and expected rates of return; and strategic alternatives to maximize value for shareholder. These statements are based on current expectations that are subject to risks, uncertainties and assumptions and Westaim can give no assurance that these expectations are correct. Westaim's actual results could differ materially from those anticipated by forward-looking statements for various reasons generally beyond our control, including but not limited to: (i) failure to complete the Acquisition; (ii) changes in market conditions or deterioration in underlying investments; (iii) general economic, market, financing, regulatory and industry developments and conditions; and (iv) other risk factors set forth in the Circular, Westaim's Annual Report or Annual Information Form. Westaim disclaims any intention or obligation to revise forward-looking statements whether as a result of new information, future developments or otherwise except as required by law. All forward-looking statements are expressly qualified in their entirety by this cautionary statement.

SOURCE Westaim Corporation

Back to top
'/>"/>
SOURCE Westaim Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine news :

1. Westaim announces 2009 third quarter results
2. Westaim announces 2009 second quarter results
3. Westaim announces 2009 first quarter results
4. Westaim enters into Management Services Agreement
5. Westaim announces 2008 year-end results
6. The Westaim Corporation requisitions meeting of shareholders of NUCRYST Pharmaceuticals to return capital to NUCRYST shareholders
7. Westaim announces 2008 third quarter results
8. Webcast Advisory - The Westaim Corporation Webcast of Conference Call to Discuss 2008 Third Quarter Results
9. Westaim terminates reorganization agreement and cancels shareholders meeting
10. Westaim to deregister its common stock in the United States
11. Westaim announces sale of iFire Technology Ltd. assets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... Amherst, Massachusetts (PRWEB) , ... March 30, 2017 , ... ... has had great success and feedback from high school and college students who have ... is being held July 7-23 and YFI is now accepting applications for enrollment. ...
(Date:3/29/2017)... (PRWEB) , ... March 30, 2017 , ... Sports Brand ... brace, which retails normally at $29.97; for the remaining days of March, the ... also been reduced to a special price of just $10 (regular retail price $19.97). ...
(Date:3/29/2017)... ... March 29, 2017 , ... ... at a Walgreens store in Mississippi. AngioGenesis Labs, makers of HeartBoost, BrainBest and ... two southeastern states. Ingredients in HeartBoost, an over the counter heart healthy drink, ...
(Date:3/29/2017)... ... 2017 , ... Based on research from Guardian’s Fourth Annual ... trying to balance both short-term and long-term benefits demands. Are employers struggling ... complexity, companies are finding that the short-term strategies used to control costs, improve ...
(Date:3/29/2017)... Horeb, WI (PRWEB) , ... March 29, 2017 , ... ... patients on early orthodontic treatment and accepting new pediatric patients, with or without a ... help young patients have a better orthodontic outcome and experience. When patients receive early ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... , March 29, 2017 Avelas Biosciences, Inc., a ... diagnosis through treatment, today announced that Carmine N. Stengone , ... company at the Needham & Company 16 th Annual Healthcare ... a.m. PDT) at the Westin Grand Central Hotel in ... ...
(Date:3/29/2017)... 2017 Research and Markets has announced the addition ... Centers & Forecast" report to their offering. ... Proton Therapy Market in Italy ... in 2016. There are currently three proton therapy centers in ... patients. In Italy , the first patients were treated ...
(Date:3/29/2017)... , Mar. 29, 2017 Research and Markets has ... Policy, Patients Treated at Proton Therapy Centers & Forecast" report to ... The South ... its current market size in 2016. The Untapped Proton Therapy Market for ... Billion USD in 2016. Proton Therapy plays an important ...
Breaking Medicine Technology: